Suppr超能文献

大型动物模型中血管化骨同种异体移植手术的新生血管形成、移植物活力和分子分析。

Neo-Angiogenesis, Transplant Viability, and Molecular Analyses of Vascularized Bone Allotransplantation Surgery in a Large Animal Model.

机构信息

Department of Orthopedic Surgery, Microvascular Research Laboratory, Mayo Clinic, 200 1st street SW55905, Building: MS-3-85, Rochester, Minnesota.

Department of Orthopedic Surgery, Orthopedic Research Laboratory, Mayo Clinic, Rochester, Minnesota.

出版信息

J Orthop Res. 2020 Feb;38(2):288-296. doi: 10.1002/jor.24481. Epub 2019 Oct 6.

Abstract

Vascularized composite allotransplantation of bone is a possible alternative treatment for large osseous defects but requires life-long immunosuppression. Surgical induction of autogenous neo-angiogenic circulation maintains transplant viability without this requirement, providing encouraging results in small animal models [1-3]. A preliminary feasibility study in a swine tibia model demonstrated similar findings [4, 5]. This study in swine tibial allotransplantation tests its applicability in a pre-clinical large animal model. Previously, we have demonstrated bone vascularized composite allotransplantation (VCA) survival was not the result of induction of tolerance nor an incompetent immune system [1]. Fourteen tibia vascularized bone allotransplants were microsurgically transplanted orthotopically to reconstruct size-matched tibial defects in Yucatan miniature swine. Two weeks of immunosuppression was used to maintain allotransplant pedicle patency during angiogenesis from a simultaneously implanted autogenous arteriovenous bundle. The implanted arteriovenous bundle was patent in group 1 and ligated in group 2 (a neo-angiogenesis control). At twenty weeks, we quantified the neo-angiogenesis and correlated it with transplant viability, bone remodeling, and gene expression. All patent arteriovenous bundles maintained patency throughout the survival period. Micro-angiographic, osteocyte cell count and bone remodeling parameters were significantly higher than controls due to the formation of a neo-angiogenic autogenous circulation. Analysis of gene expression found maintained osteoblastic and osteoclastic activity as well as a significant increase in expression of endothelial growth factor-like 6 (EGFL-6) in the patent arteriovenous bundle group. Vascularized composite allotransplants of swine tibia maintained viability and actively remodeled over 20 weeks when short-term immunosuppression is combined with simultaneous autogenous neo-angiogenesis. © 2019 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 38:288-296, 2020.

摘要

血管化复合组织同种异体移植是治疗大骨缺损的一种可行的替代方法,但需要终生免疫抑制。自体新生血管循环的手术诱导可以维持移植物的存活而无需这种要求,在小动物模型中取得了令人鼓舞的结果[1-3]。在猪胫骨模型中的初步可行性研究表明了类似的发现[4,5]。本研究在猪胫骨同种异体移植中测试了其在临床前大动物模型中的适用性。此前,我们已经证明血管化复合组织同种异体移植(VCA)的存活不是诱导耐受的结果,也不是免疫系统功能不全的结果[1]。14 个血管化的胫骨复合骨同种异体移植通过显微外科手术原位移植,以重建大小匹配的 Yucatan 小型猪的胫骨缺损。使用 2 周的免疫抑制来维持同种异体移植物蒂的通畅,在新生血管从同时植入的自体动静脉束中形成期间。在第 1 组中,植入的动静脉束是通畅的,而在第 2 组中(新生血管控制)结扎。在 20 周时,我们量化了新生血管形成,并将其与移植物的存活、骨重塑和基因表达相关联。所有通畅的动静脉束在整个存活期内都保持通畅。微血管造影、成骨细胞计数和骨重塑参数明显高于对照组,这是由于形成了新生的自体血管循环。基因表达分析发现,在通畅的动静脉束组中,成骨细胞和破骨细胞的活性保持不变,内皮生长因子样 6(EGFL-6)的表达显著增加。在短期免疫抑制与同时自体新生血管形成相结合的情况下,猪胫骨的血管化复合组织同种异体移植可维持 20 周以上的存活并进行积极的重塑。©2019 矫形研究协会。由 Wiley Periodicals, Inc. 出版。J Orthop Res 38:288-296, 2020.

相似文献

本文引用的文献

6
An overview of the regulation of bone remodelling at the cellular level.细胞水平上骨重建调节概述。
Clin Biochem. 2012 Aug;45(12):863-73. doi: 10.1016/j.clinbiochem.2012.03.021. Epub 2012 Mar 23.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验